The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methyl-6-({[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-prop-2-ynyl-amino}-methyl)-3H-quinazolin-4-one ID: ALA171641
PubChem CID: 135467876
Max Phase: Preclinical
Molecular Formula: C24H27N5O3S
Molecular Weight: 465.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C#CCN(Cc1ccc2nc(C)nc(O)c2c1)c1ccc(S(=O)(=O)N2CCN(C)CC2)cc1
Standard InChI: InChI=1S/C24H27N5O3S/c1-4-11-28(17-19-5-10-23-22(16-19)24(30)26-18(2)25-23)20-6-8-21(9-7-20)33(31,32)29-14-12-27(3)13-15-29/h1,5-10,16H,11-15,17H2,2-3H3,(H,25,26,30)
Standard InChI Key: YIBKVMNCOKLUGV-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
7.9125 -3.7000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0375 -3.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7500 -3.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3167 -3.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7375 -3.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0375 -5.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7500 -4.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3167 -4.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0917 -3.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6125 -3.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3042 -2.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3417 -4.4000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2042 -2.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3750 -3.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6043 -1.8418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1417 -4.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1417 -2.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -3.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4375 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0375 -2.5500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8917 -3.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -3.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -5.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6542 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7000 -4.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8667 -4.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9667 -2.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9625 -4.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8042 -2.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -4.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4000 -5.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2000 -3.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 18 2 0
4 2 2 0
5 1 1 0
6 7 1 0
7 23 2 0
8 6 2 0
9 1 1 0
10 19 1 0
11 1 2 0
12 1 2 0
13 30 1 0
14 28 1 0
15 13 3 0
16 5 1 0
17 5 1 0
18 22 1 0
19 26 2 0
20 2 1 0
21 10 1 0
22 21 1 0
23 31 1 0
24 9 1 0
25 9 2 0
26 25 1 0
27 24 2 0
28 17 1 0
29 16 1 0
30 10 1 0
31 22 2 0
32 8 1 0
33 14 1 0
27 19 1 0
29 14 1 0
3 7 1 0
4 8 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 465.58Molecular Weight (Monoisotopic): 465.1835AlogP: 2.22#Rotatable Bonds: 6Polar Surface Area: 89.87Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.82CX Basic pKa: 6.07CX LogP: 3.43CX LogD: 3.41Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.87
References 1. Jones TR, Varney MD, Webber SE, Lewis KK, Marzoni GP, Palmer CL, Kathardekar V, Welsh KM, Webber S, Matthews DA, Appelt K, Smith WW, Janson CA, Villafranca JE, Bacquet RJ, Howland EF, Booth CL, Herrmann SM, Ward RW, White J, Moomaw EW, Bartlett CA, Morse CA.. (1996) Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase., 39 (4): [PMID:8632414 ] [10.1021/jm9502652 ]